Standard BioTools Inc. Line of Credit Facility, Interest Rate During Period
Standard BioTools Inc. (LAB) reported Line of Credit Facility, Interest Rate During Period of 3.75% for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-26.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2015-02-26
- Standard BioTools Inc. line of credit facility, interest rate during period for the quarter ending 2014-03-31 was 3.75%.
- Standard BioTools Inc. line of credit facility, interest rate during period for fiscal 2014 was 3.75%.
| Period end | Line of Credit Facility, Interest Rate During Period 1 month | Line of Credit Facility, Interest Rate During Period 3 month | Line of Credit Facility, Interest Rate During Period 6 month | Line of Credit Facility, Interest Rate During Period 9 month | Line of Credit Facility, Interest Rate During Period 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | 3.75% 10-K · filed 2015-02-26 | ||||
| 2014-09-30 | 3.75% 10-Q · filed 2014-11-06 | ||||
| 2014-06-30 | 3.75% 10-Q · filed 2014-08-04 | ||||
| 2014-03-31 | 3.75% 10-Q · filed 2014-05-12 | ||||
| 2012-09-30 | 4.25% 10-Q · filed 2012-11-09 | ||||
| 2012-06-30 | 4.25% 10-Q · filed 2012-08-14 | ||||
| 2010-12-31 | 4.25% 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |